...
首页> 外文期刊>Journal of biomedical materials research. Part B, Applied biomaterials. >Distribution patterns of the membrane glycoprotein CD44 during the foreign-body reaction to a degradable biomaterial in rats and mice
【24h】

Distribution patterns of the membrane glycoprotein CD44 during the foreign-body reaction to a degradable biomaterial in rats and mice

机译:大鼠和小鼠异物与可降解生物材料发生异物反应过程中膜糖蛋白CD44的分布模式

获取原文
获取原文并翻译 | 示例

摘要

Although biomaterials have been used in the clinical setting for a long time, little is known of the molecular mechanisms underlying the foreign-body reaction (FBR). A good understanding of these mechanisms is requisite for the controlled regulation of the FBR needed to prevent adverse tissue reactions and thus to improve the function of the biomaterial. Macrophages are essential in the inflammatory reaction in, as well as around, the implants, and they also are believed to initiate most of the adverse responses. Typically, during the FBR macrophages become activated and fuse into multinucleated giant cells (MnGCs). CD44, an integral membrane glycoprotein expressed on a broad spectrum of cell types, is involved in MnGC formation in vitro and in inflammation processes in general. In vivo it is not known whether CD44 is part of a specific protein machinery that enables macrophage fusion or whether it has additional functions in the FBR. In the present in vivo study, CD44 expression patterns were followed in rats and mice during the FBR to a degradable collagen type I biomaterial. We found that CD44 is upregulated on all migrating cells and on newly formed blood vessels at the onset of the FBR and that MnGCs, up to week 15 postimplantation, expressed CD44. Although no evidence was found that CDP participates in macrophage fusion leading to multinucleation, it nevertheless may be an interesting target molecule for modulating the FBR in vivo, possibly by affecting cell activation, cell migration towards the biomaterial, vascularization, and MnGC formation.
机译:尽管生物材料已在临床环境中使用了很长时间,但对异物反应(FBR)的分子机制知之甚少。对这些机制的充分了解对于防止不良组织反应从而改善生物材料功能所需的FBR的可控调节至关重要。巨噬细胞在植入物中以及植入物周围的炎症反应中必不可少,并且据信它们会引发大多数不良反应。通常,在FBR期间,巨噬细胞被激活并融合成多核巨细胞(MnGC)。 CD44是一种在广泛的细胞类型中表达的不可或缺的膜糖蛋白,在体外和一般的炎症过程中均参与MnGC的形成。在体内,尚不知道CD44是否是能够实现巨噬细胞融合的特定蛋白质机制的一部分,或者在FBR中是否具有其他功能。在目前的体内研究中,在FBR期间,在大鼠和小鼠中以可降解的I型胶原生物材料追踪CD44表达模式。我们发现,在FBR发作时,所有迁移细胞和新形成的血管上的CD44均上调,而在植入后第15周,MnGCs表达CD44。尽管没有发现CDP参与巨噬细胞融合导致多核化的证据,但它可能是调节体内FBR的有趣目标分子,可能通过影响细胞活化,细胞向生物材料的迁移,血管形成和MnGC的形成。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号